EUVIMEDEUVIMED entdecken
Crossref

Characteristics and Outcomes of Patients with Atrial Versus Ventricular Secondary Tricuspid Regurgitation Undergoing Tricuspid Transcatheter Edge-to-Edge Repair – Results from the TriValve Registry

Giulio Russo, Luigi P Badano, Marianna Adamo, Hannes Alessandrini, Martin Andreas, Daniel Braun, Kim A Connelly, Paolo Denti, Rodrigo Estevez-Loureiro, Neil Fam, Mara Gavazzoni, Rebecca T Hahn und 33 weitere

European Journal of Heart Failure · 01.12.2023 · 25 (12) · 2243-2251

DOI: 10.1002/ejhf.3075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Heart Failure, online erschienen am 08.11.2023. Verfasst von Giulio Russo und 44 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biomedicine and Prevention, Cardiology Unit, Policlinico Tor Vergata, University of Rome, Rome, Italy. Hauptthemen laut MEDLINE: Tricuspid Valve Insufficiency, Heart Valve Prosthesis Implantation, Heart Failure. Die Arbeit wurde bisher 65-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim

Functional or secondary tricuspid regurgitation (STR) is the most common phenotype of tricuspid regurgitation (TR) with atrial STR (ASTR) and ventricular STR (VSTR) being recently identified as two distinct entities. Data on tricuspid transcatheter edge-to-edge repair (T-TEER) in patients with STR according to phenotype (i.e. ASTR vs. VSTR) are lacking. The aim of this study was to assess characteristics and outcomes of patients with ASTR versus VSTR undergoing T-TEER. Methods and results Patients with STR undergoing T-TEER were selected from the Transcatheter Tricuspid Valve Therapies (TriValve) registry. ASTR was defined by (i) left ventricular ejection fraction ≥50%, (ii) atrial fibrillation, and (iii) systolic pulmonary artery pressure <50 mmHg. Patients not matching these criteria were classified as VSTR. Patients with primary TR and cardiac implantable electronic device were excluded. Key endpoints included procedural success and survival at follow-up. A total of 298 patients were enrolled in the study: 65 (22%) with ASTR and 233 (78%) with VSTR. Procedural success was similar in the two groups (80% vs. 83% for ASTR vs. VSTR, p = 0.56) and TEER was effective in reducing TR in both groups (from 97% of patients with baseline TR ≥3+ to 23% in ASTR and to 15% in VSTR, all p = 0.001). At 12-month follow-up, survival was significantly higher in the ASTR versus VSTR cohort (91% vs. 72%, log-rank p = 0.02), with VSTR being an independent predictor of mortality at multivariable analysis (hazard ratio 4.75).

Conclusions

In a real-world, multicentre registry, T-TEER was effective in reducing TR grade in both ASTR and VSTR. At 12-month follow-up, ASTR showed better survival than VSTR.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tricuspid Valve InsufficiencyHeart Valve Prosthesis ImplantationHeart FailureHumansStroke VolumeTreatment OutcomeCardiac CatheterizationVentricular Function, LeftRegistries

Stichwörter der Autor:innen

Atrial secondary tricuspid regurgitationTranscatheter edge-to-edge repairTranscatheter tricuspid valve interventionsVentricular secondary tricuspid regurgitation

Autor:innen und Institutionen

  • Department of Biomedicine and Prevention, Cardiology Unit, Policlinico Tor Vergata, University of Rome, Rome, Italy.
  • Department of Medicine and Surgery, University Milano Bicocca, Milan, Italy.
  • Department of Cardiology, Auxologico IRCCS, Milan, Italy.
  • Institute of Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
  • Department of Cardiology, Asklepios clinic Sankt Georg, Hamburg, Germany.
  • Department of Cardiac Surgery, Medical University of Vienna, Vienna, Austria.

Zitieren

APA

Russo, G., Badano, L. P., Adamo, M., Alessandrini, H., Andreas, M., Braun, D., Connelly, K. A., Denti, P., Estevez-Loureiro, R., Fam, N., Gavazzoni, M., Hahn, R. T., Harr, C., Hausleiter, J., Himbert, D., Kalbacher, D., Ho, E., Latib, A., Lubos, E., …, & Taramasso, M. (2023). Characteristics and Outcomes of Patients with Atrial Versus Ventricular Secondary Tricuspid Regurgitation Undergoing Tricuspid Transcatheter Edge-to-Edge Repair – Results from the TriValve Registry. European Journal of Heart Failure, 25(12), 2243-2251. https://doi.org/10.1002/ejhf.3075

Vancouver

Russo G, Badano LP, Adamo M, Alessandrini H, Andreas M, Braun D, et al. Characteristics and Outcomes of Patients with Atrial Versus Ventricular Secondary Tricuspid Regurgitation Undergoing Tricuspid Transcatheter Edge-to-Edge Repair – Results from the TriValve Registry. European Journal of Heart Failure. 2023;25(12):2243-2251. doi:10.1002/ejhf.3075

BibTeX
@article{Russo2023,
  author = {Russo, Giulio and Badano, Luigi P and Adamo, Marianna and Alessandrini, Hannes and Andreas, Martin and Braun, Daniel and Connelly, Kim A and Denti, Paolo and Estevez-Loureiro, Rodrigo and Fam, Neil and Gavazzoni, Mara and Hahn, Rebecca T and Harr, Claudia and Hausleiter, Joerg and Himbert, Dominique and Kalbacher, Daniel and Ho, Edwin and Latib, Azeem and Lubos, Edith and Ludwig, Sebastian and Lurz, Philipp and Monivas, Vanessa and Nickenig, Georg and Pedicino, Daniela and Pedrazzini, Giovanni and Pozzoli, Alberto and Pires Marafon, Denise and Pastorino, Roberta and Praz, Fabien and Rodes-Cabau, Joseph and Besler, Christian and Schofer, Joachim and Scotti, Andrea and Piayda, Kerstin and Sievert, Horst and Tang, Gilbert H L and Thiele, Holger and Schlotter, Florian and von Bardeleben, Ralph Stephan and Webb, John and Windecker, Stephan and Leon, Martin and Maisano, Francesco and Metra, Marco and Taramasso, Maurizio},
  title = {Characteristics and Outcomes of Patients with Atrial Versus Ventricular Secondary Tricuspid Regurgitation Undergoing Tricuspid Transcatheter Edge-to-Edge Repair – Results from the TriValve Registry},
  journal = {European Journal of Heart Failure},
  year = {2023},
  volume = {25},
  number = {12},
  pages = {2243--2251},
  doi = {10.1002/ejhf.3075}
}
Kostenlos starten →